Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02698241 · ClinicalTrials.gov registry record · NA
Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT02698241 is a NA study that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 79 participants.
The verdict
NCT02698241, a NA study, was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
The INTERVENE-HF study is a prospective, non-randomized, multi-center (US only), investigational, feasibility study. The purpose of this study is to characterize safety of managing heart failure patients with integrated device diagnostics that have an implanted commercially available Medtronic cardiac resynchronization therapy defibrillator (CRT-D).
Interventions
- DEVICE Diagnostic & Medication Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02698241
The ClinicalTrials.gov registry entry for NCT02698241 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic & Medication Management is the first listed.
NCT02698241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02698241 about?
NCT02698241 is a clinical study titled "Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure". The INTERVENE-HF study is a prospective, non-randomized, multi-center (US only), investigational, feasibility study. The purpose of this study is to characterize safety of managing heart failure patients with integrated device diagnostics that have an implanted commercially available Medtronic cardi...
What is the current status of trial NCT02698241?
This trial is currently terminated. It is a NA study. The enrollment target is 79 participants. The study started on 2016-05. Estimated completion is 2018-09.
What interventions are being tested in trial NCT02698241?
The interventions under investigation include: Diagnostic & Medication Management (DEVICE).
Who is sponsoring clinical trial NCT02698241?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.